Effectiveness of interferon α-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice1   Thomas.

Slides:



Advertisements
Similar presentations
Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)
Advertisements

Celiac Disease Genetics: Current Concepts and Practical Applications Ludvig M. Sollid, Benedicte A. Lie Clinical Gastroenterology and Hepatology Volume.
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen?  Patrick Marcellin, E. Jenny Heathcote,
A Polymorphism in Interferon L3 Is an Independent Risk Factor for Development of Hepatocellular Carcinoma After Treatment of Hepatitis C Virus Infection 
Thrombocytopenia With Abnormal Liver Function Tests
Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.
Noncardiac Chest Pain Clinical Gastroenterology and Hepatology
Chronic Hepatitis C Therapy: Changing the Rules of Duration
Pichamol Jirapinyo, Christopher C. Thompson 
Effectiveness of Hepatitis B Treatment in Clinical Practice
Suna Yapali, Nizar Talaat, Anna S. Lok 
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity  Samyah Shadid, Michael D Jensen  Clinical Gastroenterology.
Michael Biermer, Thomas Berg  Gastroenterology 
Diagnosing autoimmune hepatitis in children: Is the International Autoimmune Hepatitis Group scoring system useful?  Regan L. Ebbeson, Richard A. Schreiber 
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C  Chi–Jen Chu, Munira Hussain,
GI clinical research 2002–2003: the year in review
Factors That Predict Outcome of Abdominal Operations in Patients With Advanced Cirrhosis  Dana A. Telem, Thomas Schiano, Robert Goldstone, Daniel K. Han,
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Hepatic Steatosis in Hepatitis C: Comparison of Diabetic and Nondiabetic Patients in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial 
A Patient Has a 3-Centimeter Cecal Polyp on Chronic Anticoagulation for a Mechanical Mitral Valve Prosthesis  Andrew J. Overhiser, Douglas K. Rex  Clinical.
Genetics of Colonic Polyposis
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Combination therapy with lamivudine and famciclovir for chronic hepatitis B infection  Hong Shen, Mazen Alsatie, George Eckert, Naga Chalasani, Lawrence.
Virologic Response to Therapy Increases Health-Related Quality of Life for Patients With Chronic Hepatitis B  Jeong Han Kim, So Young Kwon, Young Sok.
Early Virologic Responses and Hematologic Safety of Direct-Acting Antiviral Therapies in Veterans With Chronic Hepatitis C  Pamela S. Belperio, Elizabeth.
Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H
Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay?  Brian J. McMahon, MD, Brenna C. Simons, PhD  Clinical.
Incidence of Statin Hepatotoxicity in Patients With Hepatitis C
Severe Constipation Clinical Gastroenterology and Hepatology
Marked elevation of erythrocyte ribavirin levels in interferon and ribavirin-induced anemia  Masato Homma, Yasushi Matsuzaki, Yoichi Inoue, Minoru Shibata,
Importance of Specimen Size in Accurate Needle Liver Biopsy Evaluation of Patients With Chronic Hepatitis C  Thomas D. Schiano, Samia Azeem, Carol A.
Volume 44, Issue 2, Pages (February 2006)
Mallory–Denk Bodies Are Associated With Outcomes and Histologic Features in Patients With Chronic Hepatitis C  Mina O. Rakoski, Morton B. Brown, Robert.
Chronic Hepatitis B Virus Carriers in the Immunotolerant Phase of Infection: Histologic Findings and Outcome  Tony Andreani, Lawrence Serfaty, Djamila.
Scott J. Cotler, Manish K. Dhamija, Fabiolla Siqueira, Anna H
Hepatitis B Immunoglobulin and Lamivudine Improve Hepatitis B–Related Outcomes After Liver Transplantation: Meta-Analysis  Rohit Loomba, Ayana K. Rowley,
David H. Bruining, William J. Sandborn 
Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis.
Chronic Hepatitis C Therapy: Changing the Rules of Duration
Brendan Campbell, Benny Liu, Taft Bhuket, Robert J. Wong 
Patient-Reported Outcomes of Cirrhosis
Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg 
Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6
Genetic Factors and Hepatitis C Virus Infection
Severe autoimmune hepatitis first presenting in the early post partum period  Douglas Samuel, Stephen Riordan, Simone Strasser, Jelica Kurtovic, Indira.
Outcomes of Patients With Hepatitis B Who Developed Antiviral Resistance While on the Liver Transplant Waiting List  Melissa K. Osborn, Steven H. Han,
Esophageal variceal bleeding: Primary prophylaxis
Alan Bonder, MD, Nezam H. Afdhal, MD 
Suna Yapali, MD, Anna S. Lok, MD, FRCP 
Chronic Diarrhea Clinical Gastroenterology and Hepatology
Hepatic Cyst? Clinical Gastroenterology and Hepatology
Thrombocytopenia With Abnormal Liver Function Tests
Christos Konstantakis, Maria Karamesini, Christos Triantos 
Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication  Lauren A. Beste, George.
Chronic Hepatitis C in Patients With Persistently Normal Alanine Transaminase Levels  Mitchell L. Shiffman, Moisés Diago, Albert Tran, Paul Pockros, Robert.
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Management of Hepatitis B
Julia Lörke, Andreas Erhardt, Dieter Häussinger 
Novel Therapies for Hepatitis C Virus Based on Lessons From Virology
Clinical Gastroenterology and Hepatology
Volume 147, Issue 6, Pages (December 2014)
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
Natural Course of Asymptomatic Hepatitis C Virus–Infected Patients and Hepatocellular Carcinoma After Interferon Therapy  Takeshi Okanoue, Masahito Minami,
Robert G. Gish, Nezam H. Afdhal, Douglas T. Dieterich, K
Scott K. Fung, Anna S.F. Lok  Clinical Gastroenterology and Hepatology 
Adverse Outcomes: Why Bad Things Happen to Good People
Medical Therapy for Refractory Pediatric Crohn’s Disease
Induction Pegylated Interferon Alfa-2b in Combination With Ribavirin in Patients With Genotypes 1 and 4 Chronic Hepatitis C: A Prospective, Randomized,
Presentation transcript:

Effectiveness of interferon α-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice1   Thomas M Shehab, Robert J Fontana, Kelly Oberhelman, Jorge A Marrero, Grace L Su, Anna S.F Lok  Clinical Gastroenterology and Hepatology  Volume 2, Issue 5, Pages 425-431 (May 2004) DOI: 10.1016/S1542-3565(04)00018-7

Figure 1 Response of 153 treatment-naive hepatitis C patients to IFN/ribavirin combination therapy. ∗Biochemical response defined as normalization of ALT level. Clinical Gastroenterology and Hepatology 2004 2, 425-431DOI: (10.1016/S1542-3565(04)00018-7)